Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects
Status:
Completed
Trial end date:
2016-11-11
Target enrollment:
Participant gender:
Summary
This study evaluated change over time in neurocognitive testing in patients receiving statin
therapy in combination with evolocumab (AMG 145), compared with patients receiving statin
therapy in combination with placebo.